Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

National Institute on Drug Abuse

Behavioral Therapies Development Program - Fellowship and Training Programs


Institutional National Research Service Award (T32)


Research Training in Adolescent Drug Abuse Intervention

Liddle, Howard; University of Miami

Research has demonstrated efficacy possibilities of psychosocial interventions for drug abuse. Given the advances in drug abuse intervention research, concern has been expressed in governmental, political, and scientific communities about the shortage of scientists qualified to conduct research on the next generation of questions about drug abuse treatment effectiveness (e.g., improving retention, intervention efficacy with underserved or special populations, such as adolescents). This multisite postdoctoral training program focuses on the development of research competencies related to collaborative studies on a broad range of psychosocial interventions for adolescent drug abuse. The training program uses as a scientific and organizational infrastructure, the Center for Research on Adolescent Drug Abuse (CRADA), located at Temple University - the first treatment evaluation research center on adolescent drug abuse.

CRADA researchers began their multicultural outcome and process drug abuse treatment studies at its three sites, Temple University, University of Miami Medical School, and the University of Utah in October 1991. The program will train nine trainees over five years. The program design calls for an initial training experience in the academic research competencies necessary to conduct adolescent drug abuse psychosocial intervention research. Trainees will come to the CRADA/Temple U. for the first part of their program, the Core Seminar Series. This seven week intensive experience establishes a common foundation for the collaborative research to follow. The seminar is taught by the senior faculty (Mentoring Faculty) of the training program as well as by scholars from around the country. This group of faculty work at the three training sites with the Mentoring Faculty in the respective research programs. After the summer seminar, trainees move to a primary research training site. At the time of their application, trainees indicate a preference (through a ranking procedure) to work at one of the three training sites with a designated faculty mentor. With their mentors, trainees will plan a program of research and educational activities, tailored to needs and goals. In addition to their research at a primary site, trainees will work on a collaborative project with researchers from at least one of the other two sites. To facilitate this process, trainees will travel to their secondary sites twice during each of their two-year program. This component allows trainees to engage in collaborative projects across research environments, and substantively and structurally, positions the training program and its parent treatment evaluation research center for exciting collegial interactions and potentially rich and unique scientific contributions. In each trainee's second year, a whole program meeting (Consortium Conferences) will be held, providing a chance to present one's research to program faculty and fellow trainees. Evaluation of the individualized training program plan, with designed core themes, is based on the realization of this plan over a two-year period.


Fellowship in IV Drug Abuse Treatment Research

O'Brien, Charles; University of Pennsylvania

This program provides clinical and research training for physicians and post-doctoral students who wish to become qualified in treatment research for IV substance abusing patients, particularly as it relates to the care of those infected with or at high risk for infection with the human immuno-deficiency virus. In the process, trainees will not only be fully trained in all of the current behavioral, psychological and pharmacological techniques, but also be prepared to evaluate new treatments which may be proposed in the future and to conduct their own research on developing new treatments for existing and future alcohol and drug problems. The trainees consist of about 60% (6 of 10) board eligible psychiatrists, or physicians with backgrounds in neurology, internal medicine, pediatrics and other primary care specialities. In addition, about 40% of the fellows consist of post-doctoral students in psychology, pharmacology, neuroscience, immunology, and other related fields. Specific aims include: 1. development of trainees for leadership roles in the field of substance abuse; 2. development of excellent clinical researchers in the field of substance abuse; 3. the introduction of the basic tenets of clinical research design and the development of independent research projects; 4. the training of multivariate statistics and computer literacy with both statistical and word processing applications; 5. the development of physicians and post-doctoral students who are able to critically evaluate the substance abuse clinical research literature and make independent contributions to the literature; 6. The training of physicians and post-doctoral students who are interested in primary, secondary and tertiary prevention of substance abuse; and 7. The training of physicians and post-doctoral students who will be able to assume academic positions in medical schools and graduate departments to stimulate teaching and research at these institutions. The primary facility is the University of Pennsylvania Addiction Research Center and our clinical affiliates, including the VA Medical Centers Substance Abuse Treatment Program and the Mercy Catholic Medical Center's in-patient and ambulatory substance abuse treatment programs (Pennsteps).


Research Training Fellowship in Substance Abuse

Schottenfeld, Richard; Yale University

This program will provide post-doctoral training for physicians and psychologists preparing for careers in clinical research in substance abuse and addiction. This postdoctoral program provides future researchers and academic psychiatrists the necessary independent research skills and clinical expertise in the area of pharmacologic and non-pharmacologic treatment for drug abusers. The program involves: a structured introduction to clinical epidemiologic and treatment research; formal didactics; clinical experience in the major modalities currently used to treat drug abuse; and graduated development of teaching capabilities.

The primary goal of the postdoctoral training program is to provide future clinical researchers with the necessary independent research skills and clinical expertise to play substantive roles in the development and advancement of clinical research involving effective treatment for substance abusers. In addition to supervised clinical experience and training for teaching, the program combines a) formal course work in clinical research methodologies (core course in clinical epidemiology and biostatistics), in the responsible conduct of scientific research, and in the relevant basic and clinical sciences (core course in substance abuse treatment and research) with b) participation in on going research projects, c) mentoring by faculty preceptors, and d) development of an independent research project. Fellowship training capitalizes on the broad spectrum of Yale-affiliated clinical programs (inpatient and outpatient) and extensive research, including the Clinical Research Center for Opioid and Cocaine Abuse, Treatment Research Unit, and more than 33 funded projects.

In order to recruit future physicians early in their careers and help in the long-term development of M.D. clinical researchers involved in the field of drug abuse, the post-doctoral clinical research training program will be supplemented with a short-term research training program for medical students identified through the involvement of this research group in all four years of medical student training. Medical student trainees will be able to conduct independent research projects and complete the Yale thesis requirement through this program.

[Behavioral Therapies Development Program Index] [Funded Projects Index]

Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal